Development and validation of a survival prediction model for patients with advanced non-small cell lung cancer based on LASSO regression

Abstract

The LASSO regression model exhibited robust performance in the validation dataset, predicting survival outcomes for patients with advanced NSCLC effectively. This model can assist clinicians in making more informed treatment decisions and provide a valuable tool for patient risk stratification and personalized management.